Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting

Summary by Carroll County Mirror-Democrat
Varegacestat treatment resulted in statistically significant improvements in primary and all key secondary efficacy

6 Articles

The Norfolk Daily NewsThe Norfolk Daily News
+3 Reposted by 3 other sources
Center

Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in Adults with Progressing Desmoid Tumors at the 2026 ASCO Annual Meeting

Varegacestat treatment resulted in statistically significant improvements in primary and all key secondary efficacy

Read Full Article
Business WireBusiness Wire

Immunome Announces Detailed Phase 3 RINGSIDE Data for Varegacestat in ...

·Crystal River, United States
Read Full Article
stocktitan.netstocktitan.net

Trial drug eases pain and shrinks desmoid tumors in Phase 3 study

Phase 3 RINGSIDE trial showed varegacestat cut desmoid tumor progression or death risk by 84% and eased pain and tumor volume; NDA went to FDA in April 2026.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Carroll County Mirror-Democrat broke the news in Mount Carroll, United States on Saturday, May 30, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Bothell icon

Bothell

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal